Daniele Galanti - Publications

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Journal: Journal of clinical medicine

Published: November 23, 2025

Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.

Journal: Scientific reports

Published: July 21, 2025

Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.

Journal: Cancer immunology, immunotherapy : CII

Published: March 09, 2025

Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide.

Journal: Tumori

Published: November 11, 2022

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy.

Journal: Current oncology (Toronto, Ont.)

Published: May 20, 2022

New dosimetric parameters to predict ano-rectal toxicity during radiotherapy treatment.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: January 19, 2022

Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem.

Journal: Case reports in oncology

Published: December 12, 2021

Radiofrequency thermoablation (RFA) and radiotherapy (RT) combined treatment for bone metastases: a systematic review.

Journal: European review for medical and pharmacological sciences

Published: June 10, 2021

NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 09, 2020

Current treatment options for HER2-positive breast cancer patients with brain metastases.

Journal: Critical reviews in oncology/hematology

Published: April 16, 2020

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.

Journal: Clinical breast cancer

Published: January 07, 2019

Erratum to "Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy".

Journal: Case reports in oncological medicine

Published: January 23, 2018